GX-I7 With Cyclophosphamide in Patients With Metastatic or Recurrent Solid Tumors

NCT03733587 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: GX-I7
DRUG: Cyclophosphamide

Sponsor

Genexine, Inc.